Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

休市中 07-26 16:00:00 EDT

2.13

+0.04

+1.91%

最高2.25	最低2.07	成交量1.01万
今开2.22	昨收2.09	日振幅8.61%
总市值1.72亿	流通市值6,552万	总股本8,095万
成交额2.23万	换手率0.03%	流通股本3,076万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":2.13,"timestamp":1722024000000,"preClose":2.09,"halted":0,"volume":10088,"delay":0,"floatShares":30761835,"shares":80948832,"eps":-0.104002,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"07-26 16:00:00 EDT","open":2.22,"high":2.25,"low":2.07,"amount":22261.137142,"amplitude":0.086124,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.104002,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1571284800000,"adjPreClose":2.09,"adrRate":1,"volumeRatio":7.595241737654281},"requestUrl":"/m/hq/s/IPHA/wiki","defaultTab":"wiki","newsList":[{"id":"2454323827","title":"Innate Pharma盘中异动 快速拉升6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454323827","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454323827?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:51","pubTimestamp":1722001882,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时51分，Innate Pharma股票出现异动，股价大幅上涨6.94%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3838.83%、121.06%、68.09%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为56.23%、49.58%、28.25%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215123941fb207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215123941fb207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2454384538","title":"Innate Pharma盘中异动 临近收盘股价大跌7.52%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454384538","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454384538?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:18","pubTimestamp":1721938682,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日04时18分，Innate Pharma股票出现异动，股价快速下跌7.52%。截至发稿，该股报2.09美元/股，成交量537股，换手率0.00%，振幅5.75%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.60%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260418029eeae33d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260418029eeae33d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2453405872","title":"Innate Pharma盘中异动 早盘快速拉升6.48%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453405872","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453405872?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:00","pubTimestamp":1721743201,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日22时00分，Innate Pharma股票出现波动，股价大幅上涨6.48%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为3049.93%、1985.68%、141.43%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.，振幅分别为365.43%、133.02%、43.40%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232200019ee2c5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232200019ee2c5b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2450502539","title":"Innate Pharma盘中异动 急速拉升5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450502539","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450502539?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:05","pubTimestamp":1720793102,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时05分，Innate Pharma股票出现异动，股价大幅上涨5.97%。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为1511.14%、88.10%、39.99%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为80.37%、48.15%、32.83%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122205029f3c2602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122205029f3c2602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2450121068","title":"Innate Pharma盘中异动 临近午盘大幅跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450121068","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450121068?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:36","pubTimestamp":1720625760,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时36分，Innate Pharma股票出现异动，股价急速下挫5.09%。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为3741.32%、1294.25%、909.47%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为406.20%、133.16%、119.83%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102336009f2dfbff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102336009f2dfbff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2449706505","title":"Innate Pharma盘中异动 早盘大幅上涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706505","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449706505?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:52","pubTimestamp":1720446744,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时52分，Innate Pharma股票出现异动，股价急速上涨6.53%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Morphic Holding, Inc.、Virpax Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为642.64%、158.68%、127.84%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、33.33%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708215224af9116ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708215224af9116ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2449298349","title":"Innate Pharma盘中异动 股价大跌8.37%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449298349","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449298349?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:32","pubTimestamp":1720186323,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时32分，Innate Pharma股票出现波动，股价快速下跌8.37%。截至发稿，该股报1.97美元/股，成交量434股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.58%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052132039f0acf0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052132039f0acf0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2448527485","title":"Innate Pharma盘中异动 股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448527485","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448527485?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:00","pubTimestamp":1720015238,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时00分，Innate Pharma股票出现异动，股价大幅上涨5.83%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Cns Pharmaceuticals, Inc.、Annovis Bio, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4399.80%、25.38%、7.01%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.，振幅分别为86.67%、61.11%、49.56%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703220038941f385e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703220038941f385e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2448785918","title":"Innate Pharma盘中异动 急速拉升6.19%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448785918","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448785918?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840693,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，Innate Pharma股票出现异动，股价快速上涨6.19%。截至发稿，该股报2.06美元/股，成交量3191股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.05%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131339eed394d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131339eed394d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2446629155","title":"Innate Pharma盘中异动 快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446629155","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446629155?lang=zh_cn&edition=full","pubTime":"2024-06-28 03:11","pubTimestamp":1719515505,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日03时11分，Innate Pharma股票出现异动，股价大幅拉升5.45%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3024.51%、390.02%、364.07%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、96.88%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628031146af8f8e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628031146af8f8e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2446885319","title":"Innate Pharma盘中异动 股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446885319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446885319?lang=zh_cn&edition=full","pubTime":"2024-06-25 02:51","pubTimestamp":1719255078,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日02时51分，Innate Pharma股票出现波动，股价快速下挫5.14%。截至发稿，该股报2.03美元/股，成交量1.4336万股，换手率0.02%，振幅1.40%。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.73%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625025118af8ef158&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625025118af8ef158&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2444321212","title":"Innate Pharma盘中异动 早盘快速上涨7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444321212","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444321212?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:41","pubTimestamp":1718890902,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时41分，Innate Pharma股票出现波动，股价大幅上涨7.41%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为363.23%、168.11%、128.83%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Trevena, Inc.，振幅分别为65244.36%、30.23%、25.34%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214142aef5da8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214142aef5da8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2443631066","title":"Innate Pharma盘中异动 下午盘快速下挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443631066","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443631066?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:23","pubTimestamp":1718299421,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时23分，Innate Pharma股票出现异动，股价急速下跌5.44%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.15%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。消息层面，截至01时23分，《H.C. Wainwright维持Innate Pharma买入评级，维持目标价11.5美元》资讯为影响Innate Pharma的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614012341af8d71cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614012341af8d71cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2442394587","title":"Innate Pharma盘中异动 早盘快速下挫5.58%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442394587","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442394587?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:45","pubTimestamp":1718113535,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时45分，Innate Pharma股票出现波动，股价大幅下跌5.58%。截至发稿，该股报2.54美元/股，成交量335股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.29%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214536aef45ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214536aef45ba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2439577905","title":"Innate Pharma盘中异动 急速跳水6.48%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439577905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439577905?lang=zh_cn&edition=full","pubTime":"2024-05-30 00:12","pubTimestamp":1716999172,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日00时12分，Innate Pharma股票出现波动，股价急速跳水6.48%。截至发稿，该股报2.72美元/股，成交量6022股，换手率0.01%，振幅3.78%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.83%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530001252aef259a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530001252aef259a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2435515726","title":"Innate Pharma盘中异动 大幅跳水5.36%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435515726","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435515726?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693464,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Innate Pharma股票出现波动，股价急速下挫5.36%。截至发稿，该股报2.47美元/股，成交量7594股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.04%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131048b07d652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131048b07d652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2432607795","title":"Innate Pharma盘中异动 股价大跌6.10%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432607795","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432607795?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:20","pubTimestamp":1714659601,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时20分，Innate Pharma股票出现异动，股价快速下跌6.10%。截至发稿，该股报2.39美元/股，成交量610股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.04%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222200287cb338b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222200287cb338b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2432577806","title":"Innate Pharma盘中异动 早盘快速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432577806","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432577806?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:36","pubTimestamp":1714570565,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时36分，Innate Pharma股票出现异动，股价大幅上涨6.58%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Cytomx Therapeutics, Inc.、Tg Therapeutics, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为434.81%、36.48%、14.94%，振幅较大的相关个股有Carmell Corporation、Cytomx Therapeutics, Inc.、Palisade Bio, Inc.，振幅分别为21.50%、19.63%、14.93%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121360587e852b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121360587e852b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2431193518","title":"Innate Pharma盘中异动 快速跳水8.13%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431193518","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431193518?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:10","pubTimestamp":1714410606,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时10分，Innate Pharma股票出现波动，股价急速下挫8.13%。截至发稿，该股报2.26美元/股，成交量883股，换手率0.00%，振幅1.22%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.85%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001100779250d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001100779250d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2429593190","title":"Innate Pharma盘中异动 股价大跌5.98%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429593190","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429593190?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879104,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分，Innate Pharma股票出现波动，股价快速跳水5.98%。截至发稿，该股报2.28美元/股，成交量326股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.84%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314487a65a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314487a65a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0545},{"period":"3month","weight":-0.1341},{"period":"6month","weight":-0.2111},{"period":"1year","weight":-0.307},{"period":"ytd","weight":-0.2393}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日，是一家生物技术公司，致力于发现，开发和商业化一流的治疗性抗体，这些抗体旨在利用免疫系统来治疗严重未满足医疗需求的肿瘤适应症。该公司在免疫肿瘤学的研究和开发方面拥有丰富的经验，是了解自然杀伤细胞或NK细胞生物学的先驱。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.039613},{"month":2,"riseRate":0.2,"avgChangeRate":-0.05047},{"month":3,"riseRate":0.4,"avgChangeRate":0.011353},{"month":4,"riseRate":0.4,"avgChangeRate":-0.037436},{"month":5,"riseRate":0.2,"avgChangeRate":-0.022596},{"month":6,"riseRate":0.6,"avgChangeRate":-0.067147},{"month":7,"riseRate":0.6,"avgChangeRate":0.027123},{"month":8,"riseRate":0.5,"avgChangeRate":-0.013469},{"month":9,"riseRate":0.25,"avgChangeRate":-0.017883},{"month":10,"riseRate":0.5,"avgChangeRate":0.033636},{"month":11,"riseRate":0.4,"avgChangeRate":0.019907},{"month":12,"riseRate":0.6,"avgChangeRate":0.122297}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}